Interleukin-6 (IL-6): what your result means.

A key inflammatory cytokine involved in chronic disease and immune activation. Interleukin-6 (IL-6) is measured by blood test as part of the Inflammation panel in the HodieLabs Health Blueprint.

Why Interleukin-6 (IL-6) matters

IL-6 is a pleiotropic cytokine. Transiently elevated after exercise (myokine, beneficial) vs chronically elevated (inflammatory, harmful). Chronically elevated IL-6 predicts frailty, cognitive decline, and cardiovascular events in ageing populations.

Associated risks when out of range: Inflammaging. Cardiometabolic risk.

What the clinical evidence shows

The evidence base behind how the HodieLabs Evidence-Based Clinical Library interprets Interleukin-6 (IL-6), from randomised trials, prospective cohorts and genetic (Mendelian randomisation) studies. Full citations in the reference list below.

• IL6R Mendelian randomisation consortium (The Lancet 2012): genetic variants dampening IL-6 receptor signalling reduced coronary heart disease risk, causal evidence that the IL-6 inflammation pathway drives atherosclerosis, not merely accompanies it.
• CANTOS mechanism (Ridker et al. NEJM 2017): the cardiovascular benefit of anti-inflammatory therapy tracked with achieved reductions in the IL-6 pathway, supporting IL-6 as the upstream driver behind hs-CRP.

Evidence-based reference ranges

The HodieLabs Evidence-Based Clinical Library interprets Interleukin-6 (IL-6) against published clinical authority standards, never arbitrary "optimal" ranges. Measured in pg/mL:

Band	Range (pg/mL)
Optimal	<1.8 pg/mL
Borderline	1.8–5.0 pg/mL
High	>5.0 pg/mL
Very high	>10 pg/mL

Clinical interpretation

• IL-6 is a pleiotropic cytokine. Transiently elevated after exercise (myokine, beneficial) vs chronically elevated (inflammatory, harmful).
• Chronically elevated IL-6 predicts frailty, cognitive decline, and cardiovascular events in ageing populations.
• Test fasting, at rest, away from exercise (48h) and acute illness for accurate baseline measurement.

What improves it: the evidence-based levers

• Sleep optimisation
• Exercise
• Weight reduction
• Anti-inflammatory nutrition

Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.

How Interleukin-6 (IL-6) testing works at HodieLabs

Interleukin-6 (IL-6) is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.

References

1. The Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012;379:1214–1224.
2. Ridker PM, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease (CANTOS). N Engl J Med. 2017;377:1119–1131.

This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.